Borderline Personality Disorder Clinical Trial
Official title:
Dialectic Behavior Treatment Skills System (DBT-SS) as Treatment for Cognitively Challenged Individuals With Deliberate Self-harm
Verified date | June 2020 |
Source | Region Skane |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The study evaluates the effect of Dialectic Behavior Therapy Skills System (DBT-SS) in individuals with Intelligence Quotient 65-85 and recurrent self-harm. The study is primarily descriptive with 6 cases followed by repeated measurements (weekly; time series analysis). Primary outcome measure is frequency and severity of self-harming behavior, reported weekly 4 weeks before the start of the intervention, throughout the intervention and 12 weeks after the intervention has stopped.
Status | Completed |
Enrollment | 6 |
Est. completion date | April 1, 2020 |
Est. primary completion date | April 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Ongoing contact with adult psychiatric clinic - Intelligence Quotient 65-85 - Current self-harming behaviour at least twice the last six months - Staff from residential care or near standing persons are able to participate in the treatment by participating in group sessions. Exclusion Criteria: - Schizophrenia or Bipolar illness type 1 - Substance abuse - Non-psychiatric disorder significantly contributing to symptoms. |
Country | Name | City | State |
---|---|---|---|
Sweden | Division of Psychiatry, Region Skåne | Lund | Skåne |
Lead Sponsor | Collaborator |
---|---|
Region Skane |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Deliberate self-harm | Frequency of deliberate self-harm | Baseline - 64 weeks | |
Secondary | Problem behaviors | Frequency of problem behaviors | Baseline - 64 weeks | |
Secondary | Out-of control behavior | Number of hours per week with out-of control behavior | Baseline - 64 weeks | |
Secondary | Upset | Number of hours per week when the individual is upset | Baseline - 64 weeks | |
Secondary | Worried | Number of hours per week when the individual is worried | Baseline - 64 weeks | |
Secondary | Medication on demand | Frequency of occasions with medication on demand | Baseline - 64 weeks | |
Secondary | Visits to psychiatric emergency ward | Frequency of visits to psychiatric emergency ward | Baseline - 64 weeks | |
Secondary | Admission to hospital | Number of days admitted to hospital | Baseline - 64 weeks | |
Secondary | Coercive care | Number of days with coercive care | Baseline - 64 weeks | |
Secondary | Coercive acts | Number of coercive acts | Baseline - 64 weeks | |
Secondary | Psychotropic medications | Number of psychotropic medications | Baseline - 64 weeks | |
Secondary | Level of risk | Measurement with Short-Term Assessment of Risk and Treatability | Baseline - 64 weeks | |
Secondary | Resilience | Measurement with Short-Term Assessment of Risk and Treatability | Baseline - 64 weeks | |
Secondary | Vulnerability | Measurement with Short-Term Assessment of Risk and Treatability | Baseline - 64 weeks | |
Secondary | Level of functioning | Self-rated by interview level of functioning in daily life with WHODAS 2.0 | Baseline - 64 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Active, not recruiting |
NCT04587518 -
Five Factor Model Treatment for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT03677037 -
The Short-Term MBT Project
|
Phase 3 | |
Not yet recruiting |
NCT05989529 -
Delving Into Borderline Personality Disorder Clinical Trial Experiences
|
||
Completed |
NCT02068326 -
MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial
|
N/A | |
Completed |
NCT02518906 -
Evaluation of AIT Study
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Completed |
NCT02108990 -
Acetaminophen and Social Processes
|
Phase 2 | |
Terminated |
NCT02149823 -
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
|
Phase 1 | |
Not yet recruiting |
NCT01683136 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
|
N/A | |
Completed |
NCT02988037 -
Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study
|
N/A | |
Completed |
NCT01635556 -
Evaluation of a Modified Dialectical Behavior Therapy Program
|
N/A | |
Completed |
NCT02397031 -
Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
|
N/A | |
Terminated |
NCT01212588 -
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
|
Phase 2 | |
Terminated |
NCT01103180 -
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
|
Phase 2 | |
Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
Recruiting |
NCT05398627 -
Neurofeedback for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT03994510 -
SHame prOpensity in bOrderline Personality Disorder
|
N/A | |
Recruiting |
NCT06005129 -
Personality Change Study for Borderline Personality Disorder
|
N/A |